Search Results - "Yu, Tiffany M"
-
1
Clinical Validity/Utility, Change in Practice Patterns, and Economic Implications of Risk Stratifiers to Predict Outcomes for Early-Stage Breast Cancer: A Systematic Review
Published in JNCI : Journal of the National Cancer Institute (18-07-2012)“…At least 14 stratifiers exist to assess recurrence risk, chemotherapy response, and overall survival (OS) in women with early-stage breast cancer (ESBC). These…”
Get full text
Journal Article -
2
Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis
Published in Ophthalmology (Rochester, Minn.) (01-10-2024)Get full text
Journal Article -
3
Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening
Published in Cancer prevention research (Philadelphia, Pa.) (05-07-2023)“…The first biomarker-based cervical cancer screening test, p16/Ki-67 dual-stained cytology (DS), has been clinically validated and approved in the United States…”
Get full text
Journal Article -
4
Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non–Small-cell Lung Cancer: A Single-center Analysis
Published in Clinical lung cancer (01-01-2019)“…First-line targeted therapies have been developed for advanced non–small-cell lung cancer (NSCLC). However, small biopsy samples pose a challenge to testing…”
Get full text
Journal Article -
5
Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer
Published in PharmacoEconomics (01-12-2014)“…Background Prior economic analysis that compared the 12-gene assay to published patterns of care predicted the assay would improve outcomes while lowering…”
Get full text
Journal Article -
6
Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non–Small Cell Lung Cancer
Published in Value in health (01-11-2018)“…Genetic testing for nonsquamous advanced non–small cell lung cancer (aNSCLC) is recommended to guide first-line therapy. Activating mutations can be identified…”
Get full text
Journal Article -
7
Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Published in Journal of medical economics (03-07-2017)“…Patients with open-angle glaucoma (OAG) whose intraocular pressure is not adequately controlled by one medication have several treatment options in the US…”
Get more information
Journal Article -
8
Cost-effectiveness of adding Endocuff ® to standard colonoscopies for interval colorectal cancer screening
Published in ClinicoEconomics and outcomes research (01-01-2019)“…Higher screening colonoscopy adenoma detection rates (ADRs) correlate with reduced risk of interval colorectal cancer (CRC). The Endocuff device has been shown…”
Get full text
Journal Article -
9
Budget impact analysis of ocriplasmin for the treatment of symptomatic vitreomacular adhesion in the USA
Published in Journal of comparative effectiveness research (01-12-2018)“…Vitreomacular traction (VMT) treatment options include watchful waiting, vitrectomy and intravitreal ocriplasmin injection (Jetrea ). This analysis used…”
Get full text
Journal Article -
10
MP51-15 TEMPORARILY IMPLANTED NITINOL DEVICE VERSUS PROSTATIC URETHRAL LIFT FOR MINIMALLY INVASIVE SURGICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOMS: A MATCHING-ADJUSTED INDIRECT COMPARISON
Published in The Journal of urology (01-04-2023)Get full text
Journal Article -
11
Su1013 - Cost-Effectiveness of Adding Endocuff® to Colonoscopies for Interval Colorectal Cancer Screening
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2018)Get full text
Journal Article -
12
Author's reply to Lamy
Published in JNCI : Journal of the National Cancer Institute (16-01-2013)Get full text
Journal Article